News Network

Join oncologists nationwide who have learned from the top leaders in the lung cancer field as they share their insights on coronavirus disease 2019 (COVID-19) and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system. Led by Nathan A. Pennell, MD, PhD; Stephen Liu, MD; H. Jack West, MD; Charu Aggarwal, MD, MPH, this webinar will cover all of the key information on treating your patients with lung cancer, who could be at risk for developing COVID-19.

Speakers:

Nathan A. Pennell, MD, PhD, Associate Professor; Director, Lung Cancer Medical Oncology Program,Cleveland Clinic, Cleveland, OH

Stephen Liu, MD, Associate Professor of Medicine; Director, Thoracic Oncology, Georgetown University, Washington, DC

Charu Aggarwal, MD, MPH, Leslye M. Heisler Assistant Professor of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

H. Jack West, MD, Associate Clinical Professor in Medical Oncology; Executive Director, Employer Services, City of Hope Comprehensive
Cancer Center, Irwindale, CA

Anna F. Farago, MD, PhD, Guest Speaker; Medical Oncologist, The Center for Thoracic Cancers at Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School Boston, Massachusetts

This OncLive® webinar will focus on the impact of COVID-19 in patients with breast cancer and the innovative ways in which treatment has evolved during this time. We will feature a panel of experts from the nation’s leading cancer centers, led by Eric P. Winer, MD, to discuss important topics and key information for treating patients with breast cancer.

Topics/Objectives:

• Regional differences in the management of patients with breast cancer during the COVID-19 pandemic
• Institutional best practices for treating patients with breast cancer that have the novel coronavirus or who may be at risk for developing it
• Guidelines on the prioritization and management of patients with breast cancer

Speakers:

Eric P. Winer, MD

Professor, Medicine, Harvard Medical School

Director, Breast Oncology Center, Dana-Farber Cancer Institute

Physician Active Staff, Medicine, Brigham And Women's Hospital

Thompson Chair, Breast Cancer Research, Dana-Farber Cancer Institute

Lisa A. Carey, MD , FASCO

Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research

Deputy Director of Clinical Sciences

Lineberger Comprehensive Cancer Center

George W. Sledge Jr, MD

Professor, Medicine and Oncology

Chief of the Division of Oncology, Stanford University Medical Center

Monica Morrow, MD, FACS

Chief, Breast Service, Department of Surgery

Anne Burnett Windfohr Chair of Clinical Oncology

Memorial Sloan Kettering Cancer Center

Professor of Surgery, Weill Cornell Medical College

Sponsored by : Novartis / In association with Dana Farber